"The Company is completing 13-week pivotal toxicology studies to be submitted to the FDA for review in August."
And they should be filing for an IND for their oncology drug by the endo f this quarter -- or within six weeks.
Gamblers! Come to the table if you have the cajones.
IKT is now at $1.87.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent IKT News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/09/2024 06:41:37 PM
- Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs • GlobeNewswire Inc. • 04/18/2024 08:30:00 PM
- Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension • GlobeNewswire Inc. • 04/03/2024 12:05:00 PM
- Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity • GlobeNewswire Inc. • 03/27/2024 08:15:20 PM
- Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders • GlobeNewswire Inc. • 03/07/2024 01:30:00 PM
- Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro • GlobeNewswire Inc. • 02/28/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 12:59:02 PM
- Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers • GlobeNewswire Inc. • 02/07/2024 12:55:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:49:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:09:53 PM
- Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib • GlobeNewswire Inc. • 01/29/2024 02:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:31:03 PM
- Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli • GlobeNewswire Inc. • 01/16/2024 09:05:00 PM
- Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs • GlobeNewswire Inc. • 12/19/2023 01:30:00 PM
- Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro • GlobeNewswire Inc. • 12/04/2023 01:35:00 PM
- Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity • GlobeNewswire Inc. • 11/14/2023 09:30:06 PM
- Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023 • GlobeNewswire Inc. • 11/07/2023 02:28:32 PM
- Inhibikase Therapeutics to Report Second Quarter Financial Results on November 14, 2023 • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/16/2023 09:24:04 PM
- Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson’s Disease and Provides Update on Ongoing Enrollment • GlobeNewswire Inc. • 10/16/2023 11:00:27 AM
- Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy • GlobeNewswire Inc. • 10/04/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 03:23:58 PM
- Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib • PR Newswire (US) • 08/24/2023 12:30:00 PM
- Inhibikase Therapeutics to Present at the International Congress of Parkinson's Disease and Movement Disorders • PR Newswire (US) • 08/22/2023 12:05:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM